China's iHuman Q4 revenue falls on drop in newborn population

Reuters03-31
China's iHuman Q4 revenue falls on drop in newborn population

Overview

  • Chinese intellectual development firm's Q4 revenue declined 18% yr/yr due to drop in newborn population and conservative consumer spending

  • Adjusted EPS for Q4 fell yr/yr

  • Company approved special cash dividend totaling US$5.1 mln

Outlook

  • Company did not provide specific financial guidance for future quarters or year

Result Drivers

  • DEMOGRAPHIC PRESSURE - Revenue and MAUs declined, primarily due to a drop in China's newborn population and more conservative consumer spending, per company

  • COST CONTROL - Operating expenses decreased 16.3%, mainly due to savings in payroll-related and administrative expenses

Company press release: ID:nPn1WrgVSa

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

RMB 190.7 mln

Q4 Adjusted EPS

RMB 0.29

Q4 Gross Margin

66.90%

Q4 Gross Profit

RMB 127.5 mln

Q4 Operating Expenses

RMB 118.5 mln

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment